Glutamate carboxypeptidase II

Jun 22, 2020

Lantheus Completes Merger with Progenics

May 20, 2020

Poseida Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of P-PSMA-101 Autologous CAR-T for Metastatic Castration-Resistant Prostate Cancer

May 15, 2020

GEMoaB Announces Data Presentations Supporting Key Features of Its UniCAR Platform At the Upcoming American Association for Cancer Research (AACR) Meeting II

Feb 13, 2020

Isotopia Molecular Imaging and Eckert & Ziegler to Start Partnership for Prostate Cancer Imaging

Oct 09, 2019

GE Healthcare and Theragnostics Announce Global Commercial Partnership for Late Stage PSMA Diagnostic for Prostate Cancer

Oct 02, 2019

Theragnostics Reports Positive Clinical Trial Results from Prostate Cancer Study

Jun 27, 2019

Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics

Jun 25, 2018

Theragnostics Announces First Patient Enrolled in Their Prospective Phase II Study of 68Ga-THP-PSMA in Prostate Cancer

Feb 08, 2018

Epic Sciences To Present Single Cell PSMA Analysis To Provide Insight Into Tumor Heterogeneity And Links To Response With Anti-PSMA Therapy

Oct 03, 2017

Biotech Sector Notches Impressive Year-to-date Returns With Positive Outlook for Development of New Drugs and Therapies